1. Serum levels of vitamin D, magnesium, and calcium in patients with stable bronchial asthma
- Author
-
Laila M. Yousef, Mona T. Hussein, and Sahar Abo El-Fetoh Abdel-Wahed
- Subjects
medicine.medical_specialty ,chemistry.chemical_element ,Calcium ,magnesium ,Gastroenterology ,Pulmonary function testing ,Pathogenesis ,Internal medicine ,medicine ,Vitamin D and neurology ,In patient ,25-hydroxy vitamin d ,General Environmental Science ,Asthma ,Calcium metabolism ,lcsh:RC705-779 ,calcium ,Magnesium ,business.industry ,General Engineering ,vitamin d ,lcsh:Diseases of the respiratory system ,medicine.disease ,respiratory tract diseases ,chemistry ,General Earth and Planetary Sciences ,bronchial asthma ,business - Abstract
Background Vitamin D has multiple effects on the innate and adaptive immune system. Vitamin D has immunomodulation effects that are able to decrease the inflammatory reaction included in the bronchial asthma; thus, it plays an important effect in the asthma pathogenesis. Low serum magnesium level is associated with impaired lung function and bronchial hyperreactivity. Study design This is a prospective hospital-based study. Objective To evaluate serum levels of vitamin D, magnesium, and calcium in patients with stable bronchial asthma and their relation to asthma severity. Patients and methods A total of 65 adult patients with stable bronchial asthma and 30 healthy controls were included in the study. After clinical history taking and examination, pulmonary function tests were performed. Serum levels of 25-hydroxy vitamin D [25(OH)D], ionized calcium, and magnesium were measured in all participants. Results The mean serum levels of 25(OH)D, magnesium, and ionized calcium were significantly lower in patients with stable asthma than control participants (P
- Published
- 2019